ABG SRNE Ltd is 10% Owner at Sorrento Therapeutics, Inc. (SRNE). They have made 1 open-market trade across 1 company since 2017, most recently 2017-04-13.
CIK 0001676083
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SRNE | 1,500,000 | $461K |
Shares reported on the most recent Form 4, priced at the 2017-04-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SRNE | BUY | 2017-04-13 | 2017-04-17 | $2.00 | $5.0M | +10.5% | -15.8% | +5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.